These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 7528949

  • 1. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
    Segal HC, Hunt BJ, Cottam S, Downing A, Beard C, Francis JL, Potter D, Tan KC.
    Transplantation; 1994 Dec 27; 58(12):1356-60. PubMed ID: 7528949
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Changes in the contact system during orthotopic liver transplantation with and without aprotinin.
    Segal HC, Hunt BJ, Cottam S, Beard C, Francis JL, Potter D, Tan KC.
    Transplantation; 1995 Feb 15; 59(3):366-70. PubMed ID: 7532878
    [Abstract] [Full Text] [Related]

  • 4. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP, Molenaar IQ, Verspaget HW, Veldman MG, Palareti G, Legnani C, Moolenburgh SE, Terpstra OT, Lamers CB, van Hoek B, Porte RJ.
    Thromb Haemost; 2004 Mar 15; 91(3):506-13. PubMed ID: 14983226
    [Abstract] [Full Text] [Related]

  • 5. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P, Cabrera R, Gómez-Arnau J, Fernández MN.
    Haematologica; 1998 Apr 15; 83(4):338-46. PubMed ID: 9592984
    [Abstract] [Full Text] [Related]

  • 6. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
    Molenaar IQ, Legnani C, Groenland TH, Palareti G, Begliomini B, Terpstra OT, Porte RJ.
    Liver Transpl; 2001 Oct 15; 7(10):896-903. PubMed ID: 11679989
    [Abstract] [Full Text] [Related]

  • 7. Changes in urokinase-type plasminogen activator in orthotopic liver transplantation.
    Himmelreich G, Dooijewaard G, Breinl P, Bechstein WO, Blumhardt G, Kluft C, Riess H.
    Semin Thromb Hemost; 1993 Oct 15; 19(3):311-4. PubMed ID: 7689759
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E, Dziedziczko A, Rość D.
    Med Sci Monit; 2000 Oct 15; 6(1):103-7. PubMed ID: 11208294
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ, Boon GI, Jansen JW, Bouma BN.
    Thromb Haemost; 1993 Apr 01; 69(4):381-6. PubMed ID: 8497851
    [Abstract] [Full Text] [Related]

  • 16. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H, Du Buit C, Soria J, Touchot B, Chollet B, Commin PL, Conseiller C, Echter E, Soria C.
    Thromb Haemost; 1994 Sep 01; 72(3):438-43. PubMed ID: 7531877
    [Abstract] [Full Text] [Related]

  • 17. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Sep 01; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 18. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep 01; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 19. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 01; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 20. Mediators of fibrinolysis in orthotopic liver transplantation.
    Cheema SP, Webster NR, Dunn F, Bellamy MC.
    Clin Transplant; 1996 Feb 01; 10(1 Pt 1):24-7. PubMed ID: 8652893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.